General Information of the Compound
Compound ID
CP0534110
Compound Name
4-[2-(5-methyl-1-naphthalen-2-ylpyrazol-3-yl)oxyethyl]morpholin-3-one
    Show/Hide
Structure
Formula
C20H21N3O3
Molecular Weight
351.406
Canonical SMILES
Cc1cc(OCCN2CCOCC2=O)nn1-c1ccc2ccccc2c1
    Show/Hide
InChI
InChI=1S/C20H21N3O3/c1-15-12-19(26-11-9-22-8-10-25-14-20(22)24)21-23(15)18-7-6-16-4-2-3-5-17(16)13-18/h2-7,12-13H,8-11,14H2,1H3
    Show/Hide
InChIKey
RBPCBGOSIHOEDS-UHFFFAOYSA-N
Physicochemical Property
logP
2.57152
Rotatable Bonds
5
Heavy Atom Count
26
Polar Areas
56.59
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 57340967
ChEMBL ID
CHEMBL2170047
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki > 1000 nM
   TI
   LI
   LO
   TS